In the present study, production of VEGF increased in LPS-treated BMSCs and neutralization of VEGF with specific antibodies abolished the effects of BMSC-CM on B16M cells, while B16M and human melanoma cells given recombinant VEGF increased their adhesion and proliferation via a celecoxib-inhibitable mechanism. Here, VEGFA is linked to melanoma.